Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide, Pioglitazone, and Treosulfan in Relapsed/Refractory Multiple Myeloma
NCT01010243Phase 2Unknown
- Sponsor
- University of Regensburg
- Start
- Oct 2009
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, pioglitazone, treosulfan in multiple myeloma (MM), sponsored by University of Regensburg. Status: unknown.
02
Drugs
lenalidomidepioglitazonetreosulfan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01010243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010243.